Skip to main content
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Introduction
Featured Profiles
Genmab
Geron
SpringWorks
Special Series
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Conference Correspondent
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Small Cell Lung Cancer
Evolving Landscapes in Multiple Myeloma
OFS Summit
Multimedia
All Videos
Case-Based Exchanges
Voices From ASCO 2025
Best Practices in Breast Cancer Therapy | OFS
Interview with the Innovators
Rapid Reactions
Webinars
Quick Quiz
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Introduction
Featured Profiles
Genmab
Geron
SpringWorks
Special Series
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Conference Correspondent
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Small Cell Lung Cancer
Evolving Landscapes in Multiple Myeloma
OFS Summit
Multimedia
All Videos
Case-Based Exchanges
Voices From ASCO 2025
Best Practices in Breast Cancer Therapy | OFS
Interview with the Innovators
Rapid Reactions
Webinars
Quick Quiz
Subscribe
Videos
Combination Therapy as Maintenance in Ovarian Cancer
FEATURING:
Amina Ahmed, MD
;
Paula Anastasia, RN, MN, AOCN
;
Ali McBride, PharmD, MS
October 6, 2020
Interview with the Innovators
Watch Video
Clinical Data on First-Line Maintenance Therapy in Ovarian Cancer
FEATURING:
Amina Ahmed, MD
;
Paula Anastasia, RN, MN, AOCN
;
Ali McBride, PharmD, MS
September 15, 2020
Interview with the Innovators
Watch Video
Choosing Among PARP Inhibitors as Maintenance Therapy in Ovarian Cancer
FEATURING:
Amina Ahmed, MD
;
Paula Anastasia, RN, MN, AOCN
;
Ali McBride, PharmD, MS
September 8, 2020
Interview with the Innovators
Watch Video
Choosing Maintenance Therapy in Ovarian Cancer
FEATURING:
Amina Ahmed, MD
;
Paula Anastasia, RN, MN, AOCN
;
Ali McBride, PharmD, MS
August 18, 2020
Interview with the Innovators
Watch Video
A Review of Clinical Trials Suggesting the Use of PARP Inhibitors as First-Line Maintenance Therapy in Ovarian Cancer
FEATURING:
Amina Ahmed, MD
;
Paula Anastasia, RN, MN, AOCN
;
Ali McBride, PharmD, MS
August 11, 2020
Interview with the Innovators
Watch Video
Changes in HRD “Fingerprints” in Patients with Ovarian Cancer and Their Impact on Clinical Outcomes
FEATURING:
Amina Ahmed, MD
;
Paula Anastasia, RN, MN, AOCN
July 28, 2020
Interview with the Innovators
Watch Video
The Impact of Germline or Somatic HRD Testing on Treatment Decisions in Ovarian Cancer
FEATURING:
Paula Anastasia, RN, MN, AOCN
;
Ali McBride, PharmD, MS
July 14, 2020
Interview with the Innovators
Watch Video
The Role of Genetic Testing in Patients with Ovarian Cancer
FEATURING:
Amina Ahmed, MD
;
Paula Anastasia, RN, MN, AOCN
;
Ali McBride, PharmD, MS
June 24, 2020
Interview with the Innovators
Watch Video
What Does an Ideal Navigation Program Look Like?
FEATURING:
Katherine Sharpe, SVP ACS
March 6, 2019
2018 AONN+ Annual Conference
,
AONN+ Annual and Midyear Conference
Watch Video
Page 11 of 20
8
9
10
11
12
13
14
